MedTrace Logo

Effect of Increased Circulating Androgens on Granulosa Cell Responses to FSH.

NCT02389088 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2016-03-10

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effect of increased circulating androgens on estradiol production by the granulosa cells in response to FSH stimulus.

Conditions

  • Polycystic Ovary Syndrome

Interventions

DRUG

Letrozole

In Phase II, letrozole, 5 mg/day, will be given for 14 days

Sponsors & Collaborators

Principal Investigators

  • R. Jeffrey Chang, M.D. · University of California, San Diego

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02389088 on ClinicalTrials.gov